We are live on ! Find out more
Cetera Investment Advisers

Cetera Investment Advisers Portfolio holdings

AUM $94B
1-Year Est. Return 20.14%
This Fund
S&P 500
This Quarter Est. Return
-0.79%
1 Year Est. Return
+20.14%
3 Year Est. Return
+58.25%
5 Year Est. Return
+64.18%
10 Year Est. Return
+205.32%
AUM
$6.29B
AUM Growth
+$62.8M
Cap. Flow
+$135M
Cap. Flow %
2.14%
Top 10 Hldgs %
17.61%
Holding
1,910
New
142
Increased
848
Reduced
738
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Healthcare 5.37%
3 Financials 5.14%
4 Consumer Discretionary 4.62%
5 Communication Services 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEON icon
1726
VEON
VEON
$3.94B
$118K ﹤0.01%
2,274
+299
+15% +$14.4K
KGC icon
1727
Kinross Gold
KGC
$32.5B
$116K ﹤0.01%
21,579
-2,199
-9% -$13.2K
SABA
1728
Saba Capital Income & Opportunities Fund II
SABA
$223M
$113K ﹤0.01%
10,500
+3,437
+49% +$37.7K
BKKT icon
1729
Bakkt Inc
BKKT
$334M
$112K ﹤0.01%
+444
New +$111K
SMFG icon
1730
Sumitomo Mitsui Financial
SMFG
$160B
$112K ﹤0.01%
15,974
+5,254
+49% +$36.6K
AM icon
1731
Antero Midstream
AM
$10.2B
$108K ﹤0.01%
10,360
-14,113
-58% -$138K
CVE icon
1732
Cenovus Energy
CVE
$53.9B
$106K ﹤0.01%
+10,548
New +$90.1K
FT
1733
Franklin Universal Trust
FT
$197M
$104K ﹤0.01%
+12,880
New +$109K
EAD
1734
Allspring Income Opportunities Fund
EAD
$379M
$100K ﹤0.01%
11,333
+516
+5% +$4.61K
RIG icon
1735
Transocean
RIG
$6.19B
$99K ﹤0.01%
+26,241
New +$95.5K
NSL
1736
DELISTED
NUVEEN SENIOR INCM FD
NSL
$99K ﹤0.01%
16,846
-1,682
-9% -$9.78K
FRO icon
1737
Frontline
FRO
$8.75B
$96K ﹤0.01%
+10,224
New +$81.1K
CPRX
1738
DELISTED
Catalyst Pharmaceutical
CPRX
$94K ﹤0.01%
17,652
IAE
1739
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$93M
$93K ﹤0.01%
10,823
ADAM
1740
Adamas Trust
ADAM
$874M
$91K ﹤0.01%
5,368
-8,513
-61% -$148K
BNGO icon
1741
Bionano Genomics
BNGO
$13.1M
$90K ﹤0.01%
27
-8
-23% -$28K
FAX
1742
abrdn Asia-Pacific Income Fund
FAX
$598M
$90K ﹤0.01%
3,606
-775
-18% -$19.9K
UUUU icon
1743
Energy Fuels
UUUU
$3.61B
$88K ﹤0.01%
12,475
+1,200
+11% +$6.84K
PRVB
1744
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$88K ﹤0.01%
13,800
MUFG icon
1745
Mitsubishi UFJ Financial
MUFG
$250B
$84K ﹤0.01%
14,216
+312
+2% +$1.73K
HIO
1746
Western Asset High Income Opportunity Fund
HIO
$339M
$83K ﹤0.01%
16,040
+400
+3% +$2.1K
BBVA icon
1747
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
$80K ﹤0.01%
12,195
-613
-5% -$3.96K
LYG icon
1748
Lloyds Banking Group
LYG
$89.7B
$79K ﹤0.01%
32,067
+20
+0.1% +$49
FSM icon
1749
Fortuna Silver Mines
FSM
$3.09B
$74K ﹤0.01%
+18,734
New +$83.8K
BKT icon
1750
BlackRock Income Trust
BKT
$341M
$73K ﹤0.01%
4,000

Similar funds

Cetera Investment Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Cetera Investment Advisers held 1,910 positions worth $6.29B, up 1% from $6.23B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cetera Investment Advisers's Q3 2021 filing shows 142 new, 848 increased, 738 reduced and 126 closed positions. Its largest new stake was Ocular Therapeutix: 432,100 shares worth $4.32M. The largest sale was State Street SPDR S&P Dividend ETF, an estimated $9.18M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

  • Cetera Investment Advisers's largest Q3 2021 buy was Ocular Therapeutix: 432,100 shares worth $4.32M.
  • Cetera Investment Advisers added most to Schwab US Dividend Equity ETF in Q3 2021, an estimated $16.4M increase.
  • Cetera Investment Advisers's biggest Q3 2021 reduction was State Street SPDR S&P Dividend ETF, cutting an estimated $9.18M.
  • Cetera Investment Advisers fully exited ProShares Ultra Russell2000 in Q3 2021, selling an estimated $8.15M.
  • Cetera Investment Advisers's ten largest holdings make up 18% of its $6.29B portfolio in Q3 2021.
  • Cetera Investment Advisers opened 142 new positions and closed 126 in Q3 2021.
  • Cetera Investment Advisers's portfolio value rose 1% quarter-over-quarter to $6.29B.

Based on Cetera Investment Advisers's 13F filing for Q3 2021, filed 16 Nov 2021.